Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Caregivers draw support by mapping their relationships

Caregivers draw support by mapping their relationships

People with high and low magnesium levels in blood may have increased risk of dementia

People with high and low magnesium levels in blood may have increased risk of dementia

Researchers develop new model to better simulate blood brain barrier for study of diseases

Researchers develop new model to better simulate blood brain barrier for study of diseases

New man-made antioxidant could help improve success rates of cell-based therapies

New man-made antioxidant could help improve success rates of cell-based therapies

Scientists design method for predicting behavioral response to stimulus using neuronal oscillations

Scientists design method for predicting behavioral response to stimulus using neuronal oscillations

Researchers discover important link between Parkinson's and prion diseases

Researchers discover important link between Parkinson's and prion diseases

Researchers find unique genetic mutation in 74-year-old man with Parkinson's disease

Researchers find unique genetic mutation in 74-year-old man with Parkinson's disease

Researchers identify connections between toxoplasmosis and several brain disorders

Researchers identify connections between toxoplasmosis and several brain disorders

Brain rewiring due to dopamine loss may be source of impaired movement in Parkinson's disease

Brain rewiring due to dopamine loss may be source of impaired movement in Parkinson's disease

NIH awards $15 million to develop 3D microphysiological system platforms that model human disease

NIH awards $15 million to develop 3D microphysiological system platforms that model human disease

Simple test could identify people at risk of developing Parkinson's earlier than previously thought

Simple test could identify people at risk of developing Parkinson's earlier than previously thought

Parkinson’s disease detection by simple smell or drawing tests find two parallel studies

Parkinson’s disease detection by simple smell or drawing tests find two parallel studies

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

Researchers develop new tool to diagnose first signs of Parkinson's disease

Researchers develop new tool to diagnose first signs of Parkinson's disease

Research findings could be start of new possible treatment for Parkinson´s disease

Research findings could be start of new possible treatment for Parkinson´s disease

Researchers perform first-ever clinical trial involving genetic screening for Parkinson’s disease

Researchers perform first-ever clinical trial involving genetic screening for Parkinson’s disease

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Scientists make breakthrough in understanding the powerhouse of human cells

Scientists make breakthrough in understanding the powerhouse of human cells

Reprogrammed stem cell therapy shows promise in Parkinson's

Reprogrammed stem cell therapy shows promise in Parkinson's

Stabilizing TREM2 could be viable therapeutic strategy to combat Alzheimer's disease

Stabilizing TREM2 could be viable therapeutic strategy to combat Alzheimer's disease